Literature DB >> 23689564

Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China.

Xiaoxia Pan1, Jing Xu, Hong Ren, Wen Zhang, Yaowen Xu, Pingyan Shen, Xiao Li, Weiming Wang, Xiaonong Chen, Pei Wu, Xiaobei Feng, Cuilan Hao, Nan Chen.   

Abstract

The prevalence of chronic kidney disease (CKD) is reported to be 10.8-11.8% of the Chinese population. With economic development and longer life expectancy, the spectrum of CKD etiology has kept changing. Primary glomerular diseases (PGD) are still the most common renal diseases in China. To investigate the changing pattern of PGD in China, we retrospectively analyzed consecutive native renal biopsies performed in our hospital from 1997 to 2011. The patients were grouped according to a 3-year interval, 1997-1999 (period 1), 2000-2002 (period 2), 2003-2005 (period 3), 2006-2008 (period 4), 2009-2011 (period 5), and divided into three age groups (<20, 20-59, and ≥60 years old). 8,909 qualified cases were enrolled in this study. Among 8,909 specimens, 6,337 (71.13%) were diagnosed as PGD, while this prevalence decreased significantly from 77.61% in 1997-1999 to 66.73% in 2006-2008. IgA nephropathy (IgAN) was the most common PGD (36.66%), without any significant difference in the 5 periods (p = 0.185). IgAN was the most common PGD both in patients between the 20- to 59-year-old group (45.58%) and <20-year-old group (19.29%) as well. Membranous nephropathy (MN) was the most frequently found PGD in patients at age ≥60 years (39.64%). The frequency of MN was increased significantly from 6.48% in 1997-1999 to 22.79% in 2009-2011 (p < 0.001). The proportion of elderly patients increased significantly from 3.18% in 1997-1999 to 15.21% in 2009-2011 (p < 0.001). The prevalence of endocapillary proliferative glomerulonephritis (EnPGN) has decreased since 1997. PGD has remained the most common renal disease in China, although with a descending trend. The spectrum of PGD is different in different age groups. The frequency of EnPGN has decreased significantly, while that of MN has increased significantly.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23689564     DOI: 10.1159/000348638

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  36 in total

1.  Comparative analysis of membranous and other nephropathy subtypes and establishment of a diagnostic model.

Authors:  Hanyu Zhu; Bo Fu; Yong Wang; Jing Gao; Qiuxia Han; Wenjia Geng; Xiaoli Yang; Guangyan Cai; Xiangmei Chen; Dong Zhang
Journal:  Front Med       Date:  2018-08-10       Impact factor: 4.592

2.  Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy.

Authors:  Ming Li; Ling Wang; Dian-Chun Shi; Jia-Nee Foo; Zhong Zhong; Chiea-Chuen Khor; Chiara Lanzani; Lorena Citterio; Erika Salvi; Pei-Ran Yin; Jin-Xin Bei; Li Wang; Yun-Hua Liao; Jian Chen; Qin-Kai Chen; Gang Xu; Geng-Ru Jiang; Jian-Xin Wan; Meng-Hua Chen; Nan Chen; Hong Zhang; Yi-Xin Zeng; Zhi-Hong Liu; Jian-Jun Liu; Xue-Qing Yu
Journal:  J Am Soc Nephrol       Date:  2020-09-10       Impact factor: 10.121

3.  Efficacy and safety of glucocorticoids for patients with IgA nephropathy: a meta-analysis.

Authors:  Ge Qian; Xiaoyu Zhang; Weicheng Xu; Hequn Zou; Yongqiang Li
Journal:  Int Urol Nephrol       Date:  2019-03-06       Impact factor: 2.370

Review 4.  Management of Membranous Nephropathy in Asia.

Authors:  Jing Xu; Xiaofan Hu; Jingyuan Xie; Nan Chen
Journal:  Kidney Dis (Basel)       Date:  2015-09-01

Review 5.  The Genetics of IgA Nephropathy: An Overview from China.

Authors:  Li Zhu; Hong Zhang
Journal:  Kidney Dis (Basel)       Date:  2015-04-22

6.  Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.

Authors:  Tian-tian Li; Xiao-hui Zhang; Jing-feng Jing; Xin Li; Xiao-qian Yang; Feng-hua Zhu; Wei Tang; Jian-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2015-01-26       Impact factor: 6.150

7.  Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function.

Authors:  Yizhi Chen; Li Tang; Zhe Feng; Xueying Cao; Xuefeng Sun; Moyan Liu; Shuwen Liu; Xueguang Zhang; Ping Li; Ribao Wei; Qiang Qiu; Guangyan Cai; Xiangmei Chen
Journal:  J Nephrol       Date:  2014-02-13       Impact factor: 3.902

8.  Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China.

Authors:  Jin-Hua Hou; Hui-Xian Zhu; Min-Lin Zhou; Wei-Bo Le; Cai-Hong Zeng; Shao-Shan Liang; Feng Xu; Dan-Dan Liang; Si-Jia Shao; Ye Liu; Zhi-Hong Liu
Journal:  Kidney Dis (Basel)       Date:  2017-12-08

9.  Clinical and pathological analysis of renal biopsies of elderly patients in Northeast China: a single-center study.

Authors:  Ping Nie; Yan Lou; Yali Wang; Xue Bai; Li Zhang; Shan Jiang; Bing Li; Ping Luo
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

Review 10.  The Genetic and Environmental Factors of Primary Membranous Nephropathy: An Overview from China.

Authors:  Xiao-Dan Zhang; Zhao Cui; Ming-Hui Zhao
Journal:  Kidney Dis (Basel)       Date:  2018-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.